Dear Friends and Colleagues,
On behalf of the Local Organising Committee and the Société
Française d’Allergologie et d’Immunologie Clinique, I am honoured
and pleased to welcome you to the 22nd EAACI Congress that will
take place in Paris (France), 7-11 June 2003.
This is the fifth time that the EAACI will be meeting in France.
Previous congresses have taken place in Paris (1950), Marseille
(1971), Clermont Ferrand (1981) and again in Paris (1992).
Paris neeeds no introduction, it is one of the most attractive cities in
the world and is constantly evolving. Every year, new museums and
monuments are opening or being renovated. The venue of the
Congress, the Palais des Congrès, has recently been refurbished and
offers one of the largest centres in Europe.
The Local Organising Committee, the EAACI Executive Committee
and representatives of EAACI Sections and Interest Groups have
prepared an innovative scientific programme around the theme
“Allergy as a global problem”. This year there are over 100 sessions (4
plenary sessions, 28 main symposia, 4 mini symposia, 14 oral abstract
sessions, 12 poster discussion sessions, 8 company sponsored symposia
and a series of satellite symposia) covering all aspects of Allergy, from
basic science to diagnosis, treatment and socio-economy. An
important part of this programme highlights the development of
allergic diseases in all countries of the world with a specific emphasis
on developing countries.We hope that the scientific programme will
be of great relevance to all EAACI members as well as to non-members
who are interested in Allergy and Clinical Immunology.
This year, Le Louvre has been selected as the venue for the gala dinner.
The Grand Louvre has been reserved exclusively for the pleasure of the
EAACI Congress members. Following a visit of the museum, there
will be a cocktail and dinner party to enable those present to savour
the regional specialities of French cuisine.
This congress is the culmination of more than three years’ work, and I
must give special thanks to the wise guidance of Professor Anthony J
Frew as well as to all members of the Scientific and Social Programme
Committees whose advice and support over these years has helped us
on so many occasions.
Once again, I would like to welcome you to Paris to join us for the
22nd EAACI Congress and we all hope that you will have a memorable
scientific and social event.
President of the
Local Organising Committee
Dear colleagues and friends,
A warm welcome to Paris and to the Annual Congress of the European
Academy of Allergology and Clinical Immunology!
I hope that this historical and beautiful city may inspire us all to have a
lively and fruitful Congress.
The Local Organising Committee, under the leadership of Professor
Jean Bousquet, has done a tremendous job in putting together a
scientific programme of the highest quality, and at the same time
offering us an exciting social programme.
EAACI is very fortunate to count on its different National Societies to
organise each year a prestigious Congress. Our annual Congresses are
the backbone of our Academy, although we have a series of other
initiatives that make EAACI the leading European scientific society in
allergology and clinical immunology. Each year we organise summer
schools for our junior members and joint symposia at the meetings of
our national societies and at other scientific meetings; we have our
official journals Allergy and PAI, and our EAACI Newsletter; we offer
travel and research grants to our junior members; we sponsor our
sections, interest groups and special committees which cover the whole
area of allergology and clinical immunology and we create task forces
for writing position papers and defining some of the policies of our
Academy. Anyone interested in allergy and clinical immunology can
find something in our Academy in which he or she can participate. It is
worthwhile to become (or stay) a member of EAACI!
In April we submitted a proposal to the 6th Framework Programme of
the EU for a Network of Excellence in Allergy and Asthma. The title of
the project is GA2LEN. If we are succeesful in our bid, this will
strengthen considerably the interaction of our many research and
clinical teams and, consequently, underline the leading role of EAACI
in Europe and the world.
Dear colleagues and friends, these days in Paris are the most important
days for our Academy in 2003. Enjoy them and take something home!
Paul van Cauwenberge